Express Pharma - Page 206 of 2207 - Express Pharma

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

We, at OmniActive, invest over 10 per cent of the total outlay into R&D

30 years and counting …

Maharashtra Government appoints Rajesh Narvekar as FDA Commissioner

Biocon Biologics receives FDA approval for biosimilar YESINTEK

Express Pharma December 2024

Incubators and innovation hubs: Accelerating entrepreneurship in life sciences

Solving productivity challenges in Chemical R&D

Strengthening drug security through a resilient and affordable pharmaceutical supply chain

Lupin gains tentative USFDA nod for Sitagliptin and Metformin Hydrochloride Tablets

Granules’ net zero commitment approved by SBTi